Zobrazeno 1 - 10
of 1 398
pro vyhledávání: '"B Coiffier"'
Autor:
Herve Ghesquieres, Francesco Merli, Marita Ziepert, Qian Shi, Matthew J. Maurer, John F. Seymour, B. Coiffier, Thomas M. Habermann, Raoul Herbrecht, Tommy Fu, Christopher R. Flowers, Hervé Tilly, David Cunningham, Ulrich Jaeger, Michael Pfreundschuh, Corinne Haioun, N. Schmitz, Jocelyne Flament
Publikováno v:
Annals of Oncology. 29:1822-1827
Background Patients with diffuse large B-cell lymphoma treated with first-line anthracycline-based immunochemotherapy and remaining in remission at 2 years have excellent outcomes. This study assessed overall survival (OS) stratified by progression-f
Autor:
C. Buske, W. Kim, L. Kwak, B. Coiffier, W. Jurczak, J.M. Sancho, E. Zhavrid, J. Kim, J.Á. Hernández Rivas, A. Prokharau, M. Vasilica, R. Nagarkar, D. Osmanov, S. Lee, Y. Bae, M. Ogura
Publikováno v:
Hematological Oncology. 35:218-220
Publikováno v:
Journal of Cardiovascular Computed Tomography. 14:S58
Autor:
Christophe Fermé, Christian Gisselbrecht, Jean-François Emile, Nicolas Mounier, F. Morchhauser, Christian Recher, Jean Gabarre, B. Coiffier, H. Tilly, Corinne Haioun, D. Ranta, Raoul Herbrecht
Publikováno v:
Annals of Oncology. 20:1985-1992
Background: This study compared the induction regimens doxorubicin, cyclophosphamide and etoposide (ACE) with doxorubicin, cyclophosphamide, vincristine, bleomycin and prednisone (ACVBP) before high-dose therapy (HDT) followed by autologous stem-cell
Autor:
E. Bathelier, Stéphane Dalle, Luc Thomas, Brigitte Balme, M. Ffrench, B. Coiffier, F. Berger, G Salles
Publikováno v:
Annales de Dermatologie et de Vénéréologie. 135:748-752
Resume Introduction Il n’existe pas de criteres histologiques ou cliniques permettant de distinguer un lymphome cutane primitif de la zone marginale (PCMZL) d’une localisation secondairement cutanee d’un lymphome systemique de la zone marginale
Autor:
Manuela Mollejo, Ahmet Dogan, Francesc Solé, Emilio Iannitto, Catherine Thieblemont, Carlos Montalbán, Andrew Wotherspoon, B. Coiffier, M A Piris, Evelyne Callet-Bauchu, D Oscier, Theodora Papadaki, Alexandra Traverse-Glehen, Vito Franco, Françoise Berger, Pascale Felman, Ellen D. Remstein, Antonio Salar, Estella Matutes, Kostas Stamatopoulos
Publikováno v:
Leukemia. 22:487-495
Since the initial description of splenic marginal zone lymphoma (SMZL) in 1992, an increasing number of publications have dealt with multiple aspects of SMZL diagnosis, molecular pathogenesis and treatment. This process has identified multiple incons
Publikováno v:
Revue des Maladies Respiratoires. 24:353-357
Autor:
F. Morschhauser, N. Chouaki, Marc Wetterwald, C. Dumontet, F. Bauters, Philippe Solal-Celigny, Gerald Marit, E. Jourdan, B. Coiffier, S. Depil, R. Bouabdallah, Catherine Sebban
Publikováno v:
Annals of Oncology. 18:370-375
Single-agent gemcitabine has shown encouraging results in patients with mantle cell lymphoma (MCL). This phase II study further explored the potential of a gemcitabine-based regimen in patients with relapsed or refractory MCL. Patients70 years old re
Autor:
Gilles Salles, Michele Ghielmini, Michael Pfreundschuh, Christian Gisselbrecht, Isabelle Fleury, Catherine Thieblemont, M.H.J. van Oers, Sylvie Chevret, Michael Herold, B. Coiffier, Emanuele Zucca
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 27(3)
Background Addition of the anti-CD20 monoclonal antibody rituximab to chemotherapy improves response rates and survival in patients with B-cell non-Hodgkin lymphoma (NHL). However, rituximab induces a transient B-cell depletion and a dose-dependent T